Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alkylating Agents”

74 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 74 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01659606
What this trial is testing

Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

Who this might be right for
Dyskeratosis CongenitaHoyeraal Hreidarsson SyndromeRevesz Syndrome+1 more
Boston Children's Hospital 40
Not applicableLooking for participantsNCT07121998
What this trial is testing

Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms

Who this might be right for
Neuroendocrine (NE) TumorsEndocrine Cancer
Uppsala University 94
Testing effectiveness (Phase 2)Ended earlyNCT01397149
What this trial is testing

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Who this might be right for
Chronic Lymphocytic LeukemiaThrombocytopenia
University of Ulm 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT01627041
What this trial is testing

Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Monoblastic Leukemia+7 more
National Cancer Institute (NCI) 178
Large-scale testing (Phase 3)Study completedNCT00093470
What this trial is testing

Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Megakaryoblastic LeukemiaAdult Acute Monocytic Leukemia+14 more
National Cancer Institute (NCI) 144
Early research (Phase 1)Ended earlyNCT02548390
What this trial is testing

Study of Intravenous RXDX-107 in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Hoffmann-La Roche 70
Testing effectiveness (Phase 2)Study completedNCT02294552
What this trial is testing

Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaLymphoma+3 more
Ivan S Moiseev 200
Early research (Phase 1)Study completedNCT00102609
What this trial is testing

A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma

Who this might be right for
Soft Tissue SarcomaSarcomaNeoplasms, Connective and Soft Tissue+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 41
Large-scale testing (Phase 3)UnknownNCT01204801
What this trial is testing

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

Who this might be right for
Breast Cancer
Medifocus, Inc. 238
Large-scale testing (Phase 3)Looking for participantsNCT05991908
What this trial is testing

Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Shanghai Jiao Tong University School of Medicine 222
Testing effectiveness (Phase 2)Study completedNCT00050427
What this trial is testing

ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasmsNeoplasms by Site+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53
Testing effectiveness (Phase 2)Ended earlyNCT00655395
What this trial is testing

Treatment of Elderly Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic (MD) Syndrome With Laromustine and Infusional Cytarabine

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
Viron Therapeutics Inc 25
Not applicableStudy completedNCT03840824
What this trial is testing

Blood Spot Self-administered Test and Assay

Who this might be right for
Dysfunction; EndocrineEffects of ChemotherapyPremature Ovarian Failure
University of Pennsylvania 80
Testing effectiveness (Phase 2)Study completedNCT03349450
What this trial is testing

DPX-Survivac and Checkpoint Inhibitor in DLBCL

Who this might be right for
Adult Diffuse Large Cell LymphomaRecurrentAdult Refractory Diffuse Large B-Cell Lymphoma
Sunnybrook Health Sciences Centre 25
Large-scale testing (Phase 3)UnknownNCT02856048
What this trial is testing

Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer

Who this might be right for
CancerToxicity Due to ChemotherapySarcoma+3 more
Assistance Publique - Hôpitaux de Paris 11
Early research (Phase 1)Ended earlyNCT00623077
What this trial is testing

MT2004-30: Tomotherapy for Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more
Masonic Cancer Center, University of Minnesota 23
Testing effectiveness (Phase 2)Study completedNCT00313586
What this trial is testing

Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+12 more
National Cancer Institute (NCI) 197
Testing effectiveness (Phase 2)Ended earlyNCT00365274
What this trial is testing

SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI) 6
Early research (Phase 1)Study completedNCT01834248
What this trial is testing

DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAlkylating Agent-Related Acute Myeloid LeukemiaChronic Myelomonocytic Leukemia+2 more
Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT01864109
What this trial is testing

Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma

Who this might be right for
Newly Diagnosed Ewing Sarcoma
Memorial Sloan Kettering Cancer Center 83
Load More Results